SO
57
6
HBI
58
3
MU
28
-3
SBUX
37
-2
CFG
74
2
LUV
45
-2
TMO
42
-6
A
37
-2
ESS
62
-3
AN
50
-5
STZ
52
-6
THC
60
-5
MCD
52
-5
PCAR
56
-5
IFF
47
-4
AMAT
33
-13
GILD
47
-8
KR
36
-6
RSG
65
-3
BK
74
3
SO
57
6
HBI
58
3
MU
28
-3
SBUX
37
-2
CFG
74
2
LUV
45
-2
TMO
42
-6
A
37
-2
ESS
62
-3
AN
50
-5
STZ
52
-6
THC
60
-5
MCD
52
-5
PCAR
56
-5
IFF
47
-4
AMAT
33
-13
GILD
47
-8
KR
36
-6
RSG
65
-3
BK
74
3
Financhill
Back

RiverFront Strategic Income ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
35

RIGS
RiverFront Strategic Income ETF

Last Price:
22.89
Seasonality Move:
0.14%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
35
RiverFront Strategic Income ETF (RIGS) is a Sell

Is RiverFront Strategic Income ETF a Buy, Sell or Hold?

  • The current RiverFront Strategic Income ETF [RIGS] share price is $22.98. The Score for RIGS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RIGS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RIGS Stock Price Chart

What is RiverFront Strategic Income ETF's stock price today?

  • The RiverFront Strategic Income ETF share price today is $22.98
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RIGS is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

RIGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 45.34 Sell
Chaikin Money Flow: 333 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.92 - 23.18) Sell
Bollinger Bands (100): (22.89 - 23.45) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

RIGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23 Sell
20-day SMA: 23 Sell
50-day SMA: 23.25 Sell
200-day SMA: 22.97 Buy
8-day EMA: 23 Sell
20-day EMA: 23.04 Sell
50-day EMA: 23.13 Sell
200-day EMA: 23.01 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

RiverFront Strategic Income ETF Earnings Growth & RIGS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

RiverFront Strategic Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):